Application

15435697 · 4-(8-METHOXY-1-((1-METHOXYPROPAN-2-YL)-2-(TETRAHYDRO-2H-PYRAN-4-YL)-1 H-IMIDAZO[4,5-C]QUINOLIN-7-YL)-3,5-DIMETHYLISOXAZOLE AND ITS USE AS BROMODOMAIN INHIBITOR

Filed 2017-02-17 · Granted · Patent 9861627 (2018-01-09) The official file ↗The patent and its PDF ↗ · Art unit 1625 · Examiner Heidi L Reese Easy · CPC A61K 31/4745 · GlaxoSmithKline LLC · GlaxoSmithKline

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

2.9 mo

to disposition 10.7 mo

Statutes raised

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.